BUY Wolverine 10BPC/10TB
Wolverine 10BPC/10TB is a popular high-potency “recovery stack” consisting of two regenerative peptides: BPC-157 (10mg) and TB-500 (10mg), usually combined in a single 20mg vial. It is named after the fictional character “Wolverine” due to the purported ability of these peptides to drastically accelerate the healing of muscle, bone, and connective tissue.
Core Components & Mechanisms
- BPC-157 (Body Protection Compound): A 15-amino acid peptide that promotes angiogenesis (vessel growth) and increases the expression of growth hormone receptors in fibroblasts. It is primarily used to heal “hypovascular” areas like tendons and ligaments that naturally receive poor blood flow.
- TB-500 (Thymosin Beta-4 fragment): A synthetic version of a naturally occurring protein that promotes cell migration to the site of an injury. It is particularly effective at reducing systemic inflammation and increasing flexibility by preventing the formation of excessive scar tissue (adhesions).
Primary Research Uses
- Accelerated Soft Tissue Repair: Used to treat acute and chronic injuries, including rotator cuff tears, Achilles tendonitis, and meniscus damage.
- Systemic Anti-Inflammation: Researched for its ability to lower systemic inflammation markers, aiding in recovery from high-intensity athletic training.
- Wound and Skin Healing: Investigated for accelerating the healing of surgical incisions and deep skin burns.
- Joint Longevity: Often used in longevity research to maintain joint integrity and prevent age-related wear and tear.
Preparation and Handling
- Format: Supplied as a lyophilized (freeze-dried) powder in a single vial.
- Reconstitution: Requires Bacteriostatic Water for injection.
- Storage: Must be stored in a refrigerator (2°C–8°C) once reconstituted. The peptide chain is fragile; the vial should be swirled gently rather than shaken.
- Administration: Typically administered via subcutaneous injection near the site of the injury or systemically in the abdomen.
Safety and Regulatory Status
- FDA Status: As of 2026, the components of this stack are not FDA-approved for human consumption. The FDA has categorized BPC-157 as a “Category 2” substance,
- restricting compounding pharmacies from distributing it for general use.
- WADA Status: Strictly Prohibited. Both BPC-157 and TB-500 are banned at all times (in and out of competition) by the World Anti-Doping Agency (WADA) under “Non-Approved Substances” and “Peptide Hormones/Growth Factors.”
- Side Effects: Potential effects include nausea, lightheadedness, and injection site irritation. Long-term effects on human subjects are still being studied in clinical trials.
Note: For verified research-grade peptides, scientists often source from Peptide Sciences or Cayman Chemical. Always consult a healthcare professional at an institution like the Mayo Clinic for injury management.





Reviews
There are no reviews yet.